Elexacaftor is a medication used in combination with two other drugs, tezacaftor and ivacaftor, to treat cystic fibrosis (CF). It specifically targets the underlying cause of the disease by improving the function of the defective CFTR protein, which is responsible for the symptoms of CF.
